12
Participants
Start Date
April 20, 2004
Primary Completion Date
August 23, 2007
Study Completion Date
August 23, 2007
rV-CEA(6D)/TRICOM-rF-CEA(6D)/TRICOM
rF-CEA(6D)/TRICOM
Recombinant Fowlpox-GM-CSF
Celecoxib
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda
National Cancer Institute (NCI)
NIH